Celltrion | 068270 - Eigenkapital Und Reserven

Aktienkurs
206,000.00
Täglich Wechseln
2,000.00 0.98%
Monatlich
-13.99%
Jährlich
12.32%
Q1 Prognose
201,705.00




Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.8M 858K 2025-09
Avita Medical AUD -16.65M 3.76M 2025-12
Celltrion KRW 16.7T 182.36B 2025-09
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
IQVIA Holdings USD 6.5B 343M 2025-12
Moderna USD 8.65B 680M 2025-12
Organon & Co USD 906M 173M 2025-09
Revvity USD 7.38B 180.27M 2025-09
Tectonic Therapeutic USD 267.53M 16.24M 2025-09
Viatris USD 15.22B 352.9M 2025-09
Xeris Pharmaceuticals USD -861K 18.44M 2025-09